Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunbo Dong

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Environmental Microbiome|June 4, 2026
The microecological mechanism of Cordyceps chanhua promoting soil nitrogen cyclingGongping Hu, Youcui Yang, Tao Wang, et al.
Nature Immunology|September 17, 2020
Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signalingChuanhui Han, Zhida Liu, Yunjia Zhang, et al.
Theranostics|September 30, 2024
Developing an enhanced chimeric permuted intron-exon system for circular RNA therapeuticsLei Wang, Chunbo Dong, Weibing Zhang, et al.
Science Immunology|August 11, 2019
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunityZhida Liu, Chuanhui Han, Chunbo Dong, et al.
Materials Today. Bio|December 16, 2025
A tripartite therapeutic agent reprograms the myocardial infarction microenvironmentKaiyi Zhu, Xiaozhe Wang, Qian Yang, et al.
Frontiers in Immunology|April 15, 2025
Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virusWeibing Zhang, Lei Wang, Liyu Chu, et al.
Molecular Biomedicine|October 14, 2025
Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19Yongfeng Qiao, Yanjun Han, Lu Zhao, et al.
Cell Reports|October 14, 2025
CircRNA vaccine encoding a chimeric immunogen of B6 and M1 demonstrates robust immune responses against MPXVJiahao Wu, Wei Rou, Zhengrong Gao, et al.
Cell Reports. Medicine|May 2, 2022
AXL targeting restores PD-1 blockade sensitivity of <i>STK11/LKB1</i> mutant NSCLC through expansion of TCF1<sup>+</sup> CD8 T cellsHuiyu Li, Zhida Liu, Longchao Liu, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Environmental Microbiome|June 4, 2026
The microecological mechanism of Cordyceps chanhua promoting soil nitrogen cyclingGongping Hu, Youcui Yang, Tao Wang, et al.
Nature Immunology|September 17, 2020
Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signalingChuanhui Han, Zhida Liu, Yunjia Zhang, et al.
Theranostics|September 30, 2024
Developing an enhanced chimeric permuted intron-exon system for circular RNA therapeuticsLei Wang, Chunbo Dong, Weibing Zhang, et al.
Science Immunology|August 11, 2019
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunityZhida Liu, Chuanhui Han, Chunbo Dong, et al.
Materials Today. Bio|December 16, 2025
A tripartite therapeutic agent reprograms the myocardial infarction microenvironmentKaiyi Zhu, Xiaozhe Wang, Qian Yang, et al.
Frontiers in Immunology|April 15, 2025
Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virusWeibing Zhang, Lei Wang, Liyu Chu, et al.
Molecular Biomedicine|October 14, 2025
Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19Yongfeng Qiao, Yanjun Han, Lu Zhao, et al.
Cell Reports|October 14, 2025
CircRNA vaccine encoding a chimeric immunogen of B6 and M1 demonstrates robust immune responses against MPXVJiahao Wu, Wei Rou, Zhengrong Gao, et al.
Cell Reports. Medicine|May 2, 2022
AXL targeting restores PD-1 blockade sensitivity of <i>STK11/LKB1</i> mutant NSCLC through expansion of TCF1<sup>+</sup> CD8 T cellsHuiyu Li, Zhida Liu, Longchao Liu, et al.
Pageof 7